Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET

被引:9
|
作者
Silva-Rudberg, Jason A. [1 ,2 ]
Salardini, Elaheh [1 ,2 ]
O'Dell, Ryan S.
Chen, Ming-Kai [3 ]
Ra, Jocelyn [1 ,2 ]
Georgelos, Jamie K. [1 ,2 ]
Morehouse, Mackenzie R. [1 ,2 ]
Melino, Kaitlyn P. [1 ,2 ]
Parma, Pradeep [3 ]
Toyonaga, Takuya [3 ]
Nabulsi, Nabeel B. [3 ]
Huang, Yiyun [3 ]
Carson, Richard E. [3 ]
van Dyck, Christopher H. [2 ,3 ]
Mecca, Adam P. [1 ,2 ,4 ]
机构
[1] Yale Univ, Alzheimers Dis Res Unit, Sch Med, New Haven, CT USA
[2] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT USA
[3] Yale Univ, Dept Radiol & Biomed Imaging, Sch Med, New Haven, CT USA
[4] Yale Univ, Alzheimers Dis Res Unit, Sch Med, One Church St,8th Floor, New Haven, CT 06510 USA
来源
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; diffusion tensor imaging; synaptic density; gray matter microstructure SV2A; positron emission tomography; VOLUME; DIFFUSIVITY; PROGRESSION; BURDEN; RISK; TAU; MCI;
D O I
10.1016/j.jagp.2023.08.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: Multimodal imaging techniques have furthered our understanding of how different aspects of Alzheimer's disease (AD) pathology relate to one another. Diffusion tensor imaging (DTI) measures such as mean diffusivity (MD) may be a surrogate measure of the changes in gray matter structure associated with AD. Positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) has been used to quantify synaptic loss, which is the major pathological correlate of cognitive impairment in AD. In this study, we investigated the relationship between gray matter microstructure and syn-aptic density. Methods: DTI was used to measure MD and [11C]UCB-J PET to measure synaptic density in 33 amyloid-positive participants with AD and 17 amyloid-negative cognitively normal (CN) participants aged 50-83. Univari-ate regression analyses were used to assess the association between synaptic density and MD in both the AD and CN groups. Results: Hippocampal MD was inversely associated with hippocampal synaptic density in participants with AD (r = -0.55, p <0.001, df = 31) but not CN (r = 0.13, p = 0.62, df = 15). Explor-atory analyses across other regions known to be affected in AD suggested wide-spread inverse associations between synaptic density and MD in the AD group. Conclusion: In the setting of AD, an increase in gray matter MD is inversely asso-ciated with synaptic density. These co-occurring changes may suggest a link between synaptic loss and gray matter microstructural changes in AD. Imaging studies of gray matter microstructure and synaptic density may allow important insights into AD-related neuropathology. (Am J Geriatr Psychiatry 2024; 32:17-28)
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [31] Tracer kinetic analysis of the SV2A ligand 11C-UCBA as a PET marker for synaptic density in humans
    Lubberink, Mark
    Appel, Lieuwe
    Gaging, Johannes
    Lindskog, Karolina
    Danfors, Torsten
    Larsson, Elna-Marie
    Kumlien, Eva
    Antoni, Gunnar
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [32] In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET
    Thomsen, Majken B.
    Jacobsen, Jan
    Lillethorup, Thea P.
    Schacht, Anna C.
    Simonsen, Mette
    Romero-Ramos, Marina
    Brooks, David J.
    Landau, Anne M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (04): : 819 - 830
  • [33] [11C]UCB-J PET imaging of synaptic vesicle protein SV2A in cognitive decline
    DiFilippo, Alexandra
    Tullis, Tyler
    Zammit, Matthew
    Murali, Dhanabalan
    McKinney, Grace
    Davenport, Nancy
    Barnhart, Todd
    Betthauser, Tobey
    Engle, Jonathan
    Stone, Charles
    Johnson, Sterling
    Bendlin, Barbara
    Christian, Bradley
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [34] Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates
    Li, Songye
    Cai, Zhengxin
    Wu, Xiaoai
    Holden, Daniel
    Pracitto, Richard
    Kapinos, Michael
    Gao, Hong
    Labaree, David
    Nabulsi, Nabeel
    Carson, Richard E.
    Huang, Yiyun
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (03): : 1544 - 1554
  • [35] Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A
    Onwordi, Ellis Chika
    Whitehurst, Thomas
    Shatalina, Ekaterina
    Mansur, Ayla
    Arumuham, Atheeshaan
    Osugo, Martin
    Marques, Tiago Reis
    Jauhar, Sameer
    Gupta, Susham
    Mehrotra, Ravi
    Rabiner, Eugenii A.
    Gunn, Roger N.
    Natesan, Sridhar
    Howes, Oliver D.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (07) : 639 - 646
  • [36] Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease
    Brown, Christopher
    Das, Sandhitsu
    Xie, Long
    Nasrallah, Ilya
    Detre, John
    Chen-Plotkin, Alice
    Shaw, Leslie
    McMillan, Corey
    Yushkevich, Paul
    Wolk, David
    ALZHEIMERS & DEMENTIA, 2024, 20 (06) : 4147 - 4158
  • [37] Monitoring synaptic loss in a rat model of stroke: a PET imaging study with [18F]SynVesT-2, radiotracer for the synaptic vesicle protein 2A (SV2A)
    Lyu, Xueying
    Toyonaga, Takuya
    Deng, Gang
    Huang, Yiyun
    Carson, Richard
    Zhou, Jiangbing
    Cai, Zhengxin
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [38] Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB-J
    Mecca, Adam P.
    O'Dell, Ryan S.
    Sharp, Emily S.
    Banks, Emmie R.
    Bartlett, Hugh H.
    Zhao, Wenzhen
    Lipior, Sylwia
    Diepenbrock, Nina G.
    Chen, Ming-Kai
    Naganawa, Mika
    Toyonaga, Takuya
    Nabulsi, Nabeel B.
    Vander Wyk, Brent C.
    Arnsten, Amy F. T.
    Huang, Yiyun
    Carson, Richard E.
    van Dyck, Christopher H.
    ALZHEIMERS & DEMENTIA, 2022, 18 (12) : 2527 - 2536
  • [39] [11C]UCB-J: A novel PET tracer for imaging the synaptic vesicle glycoprotein 2A (SV2A)
    Nabulsi, Nabeel
    Hannestad, Jonas
    Holden, Daniel
    Mercier, Joel
    Najafzadeh, Soheila
    Lin, Shu-fei
    Labaree, David
    Laruelle, Marc
    Carson, Richard
    Huang, Yiyun
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [40] Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers
    Cristian C. Constantinescu
    Cedric Tresse
    MingQiang Zheng
    Alexandra Gouasmat
    Vincent M Carroll
    Laetitia Mistico
    David Alagille
    Christine M. Sandiego
    Caroline Papin
    Kenneth Marek
    John P. Seibyl
    Gilles D. Tamagnan
    Olivier Barret
    Molecular Imaging and Biology, 2019, 21 : 509 - 518